BRIEF-BlackRock Inc's Long Position In Fosun Pharma Rises To 6.39% - HKEX Filing
BRIEF-BlackRock Inc's Long Position In Fosun Pharma Rises To 6.39% - HKEX Filing
簡介-貝萊德公司在復星國際製藥的多頭頭寸上升至6.39%-港交所備案
Source text Further company coverage: 2196.HK 600196.SS Oct 5 (Reuters) - Hong Kong stock exchange filing:
路透10月5日電-香港交易所備案文件：
* BLACKROCK INC'S LONG POSITION IN SHANGHAI FOSUN PHARMACEUTICAL 2196.HK INCREASED TO 6.39% ON SEPT 30 FROM
*貝萊德公司在復星醫藥2196.HK的多頭頭寸從9月30日增加到6.39%.
5.84% - HKEX FILING
5.84%-港交所備案
Source text Further company coverage: 2196.HK 600196.SS
來源文本進一步公司報道：2196.HK 600196.SS
(Reporting by Hong Kong newsroom)
(香港新聞編輯部報道)
((twinnie.siu@tr.com; 852-3462 7715;))
(twinnie.siu@tr.com；852-3462 7715；)
資訊熱榜
更新時間